TK, R., SN, B., DM, S., Z, I., AM, B., HR, O., . . . CG, L. (2025). Escitalopram for agitation in Alzheimer's dementia: A randomized controlled phase 3 trial. Nature medicine, 31(5), 1586. https://doi.org/10.1038/s41591-025-03569-y
Chicago Style (17th ed.) CitationTK, Rajji, et al. "Escitalopram for Agitation in Alzheimer's Dementia: A Randomized Controlled Phase 3 Trial." Nature Medicine 31, no. 5 (2025): 1586. https://doi.org/10.1038/s41591-025-03569-y.
MLA (9th ed.) CitationTK, Rajji, et al. "Escitalopram for Agitation in Alzheimer's Dementia: A Randomized Controlled Phase 3 Trial." Nature Medicine, vol. 31, no. 5, 2025, p. 1586, https://doi.org/10.1038/s41591-025-03569-y.
Warning: These citations may not always be 100% accurate.